The chaperone nucleophosmin (NPM1) is over-expressed in the epithelial compartment of prostate tumours compared to adjacent healthy epithelium and may represent one of the key actors that support the neoplastic phenotype of prostate adenocarcinoma cells. Yet, the mechanisms that underlie NPM1 mediated phenotype remain elusive in the prostate. To better understand NPM1 functions in prostate cancer cells, we sought to characterize its impact on prostate cancer cells behaviour and decipher the mechanisms by which it may act. Here we show that NPM1 favors prostate tumour cell migration, invasion and colony forming. Furthermore, knockdown of NPM1 leads to a decrease in the growth of LNCaP-derived tumours grafted in Nude mice in vivo. Such oncogenic-like properties are found in conjunction with a positive regulation of NPM1 on the ERK1/2 (Extracellular signal-Regulated Kinases 1/2) kinase phosphorylation in response to EGF (Epidermal Growth Factor) stimulus, which is critical for prostate cancer progression following the setting of an autonomous production of the growth factor. NPM1 could then be a target to switch off specifically ERK1/2 pathway activation in order to decrease or inhibit cancer cell growth and migration.
References
[1]
Leotoing L, Meunier L, Manin M, Mauduit C, Decaussin M, et al. (2008) Influence of nucleophosmin/B23 on DNA binding and transcriptional activity of the androgen receptor in prostate cancer cell. Oncogene 27: 2858–2867. doi: 10.1038/sj.onc.1210942
[2]
Szebeni A, Herrera JE, Olson MO (1995) Interaction of nucleolar protein B23 with peptides related to nuclear localization signals. Biochemistry 34: 8037–8042. doi: 10.1021/bi00025a009
[3]
Okuwaki M, Matsumoto K, Tsujimoto M, Nagata K (2001) Function of nucleophosmin/B23, a nucleolar acidic protein, as a histone chaperone. FEBS Lett 506: 272–276. doi: 10.1016/s0014-5793(01)02939-8
[4]
Takemura M, Sato K, Nishio M, Akiyama T, Umekawa H, et al. (1999) Nucleolar protein B23.1 binds to retinoblastoma protein and synergistically stimulates DNA polymerase alpha activity. J Biochem 125: 904–909. doi: 10.1093/oxfordjournals.jbchem.a022367
[5]
Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, et al. (2000) Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 103: 127–140. doi: 10.1016/s0092-8674(00)00093-3
[6]
Lindstrom MS (2011) NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling. Biochem Res Int 2011: 195209. doi: 10.1155/2011/195209
[7]
Okuwaki M (2008) The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein. J Biochem 143: 441–448. doi: 10.1093/jb/mvm222
[8]
Tanaka M, Sasaki H, Kino I, Sugimura T, Terada M (1992) Genes preferentially expressed in embryo stomach are predominantly expressed in gastric cancer. Cancer Res 52: 3372–3377.
[9]
Nozawa Y, Van Belzen N, Van der Made AC, Dinjens WN, Bosman FT (1996) Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J Pathol 178: 48–52. doi: 10.1002/(sici)1096-9896(199601)178:1<48::aid-path432>3.0.co;2-y
[10]
Sari A, Calli A, Altinboga AA, Pehlivan FS, Gorgel SN, et al. (2011) Nucleophosmin expression in renal cell carcinoma and oncocytoma. Apmis 120: 187–194. doi: 10.1111/j.1600-0463.2011.02835.x
[11]
Shields LB, Gercel-Taylor C, Yashar CM, Wan TC, Katsanis WA, et al. (1997) Induction of immune responses to ovarian tumor antigens by multiparity. J Soc Gynecol Investig 4: 298–304. doi: 10.1016/s1071-5576(97)00068-3
[12]
Di Fiore PP (2008) Playing both sides: nucleophosmin between tumor suppression and oncogenesis. J Cell Biol 182: 7–9. doi: 10.1083/jcb.200806069
[13]
Brady SN, Yu Y, Maggi LB Jr, Weber JD (2004) ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway. Mol Cell Biol 24: 9327–9338. doi: 10.1128/mcb.24.21.9327-9338.2004
[14]
Li QF, Tang J, Liu QR, Shi SL, Chen XF (2010) Localization and altered expression of nucleophosmin in the nuclear matrix during the differentiation of human hepatocarcinoma SMMC-7721 cells induced by HMBA. Cancer Invest 28: 1004–1012. doi: 10.3109/07357900902918452
[15]
Liu Y, Zhang F, Zhang XF, Qi LS, Yang L, et al. (2012) Expression of Nucleophosmin/NPM1 correlates with migration and invasiveness of colon cancer cells. J Biomed Sci 19: 53. doi: 10.1186/1423-0127-19-53
[16]
Davies P, Eaton CL (1989) Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate. Prostate 14: 123–132. doi: 10.1002/pros.2990140206
[17]
Scher HI, Sarkis A, Reuter V, Cohen D, Netto G, et al. (1995) Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms. Clin Cancer Res 1: 545–550.
[18]
Tillotson JK, Rose DP (1991) Endogenous secretion of epidermal growth factor peptides stimulates growth of DU145 prostate cancer cells. Cancer Lett 60: 109–112. doi: 10.1016/0304-3835(91)90216-5
[19]
Traish AM, Wotiz HH (1987) Prostatic epidermal growth factor receptors and their regulation by androgens. Endocrinology 121: 1461–1467. doi: 10.1210/endo-121-4-1461
[20]
Jones HE, Eaton CL, Barrow D, Dutkowski CM, Gee JM, et al. (1997) Comparative studies of the mitogenic effects of epidermal growth factor and transforming growth factor-alpha and the expression of various growth factors in neoplastic and non-neoplastic prostatic cell lines. Prostate 30: 219–231. doi: 10.1002/(sici)1097-0045(19970301)30:4<219::aid-pros1>3.0.co;2-g
[21]
Junttila MR, Li SP, Westermarck J (2008) Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. Faseb J 22: 954–965. doi: 10.1096/fj.06-7859rev
[22]
Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T (2003) Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253: 269–285. doi: 10.1023/a:1026028303196
[23]
Shandilya J, Swaminathan V, Gadad SS, Choudhari R, Kodaganur GS, et al. (2009) Acetylated NPM1 localizes in the nucleoplasm and regulates transcriptional activation of genes implicated in oral cancer manifestation. Mol Cell Biol 29: 5115–5127. doi: 10.1128/mcb.01969-08
[24]
Inder KL, Lau C, Loo D, Chaudhary N, Goodall A, et al. (2009) Nucleophosmin and nucleolin regulate K-Ras plasma membrane interactions and MAPK signal transduction. J Biol Chem 284: 28410–28419. doi: 10.1074/jbc.m109.001537
[25]
Inder KL, Hill MM, Hancock JF (2010) Nucleophosmin and nucleolin regulate K-Ras signaling. Commun Integr Biol 3: 188–190. doi: 10.4161/cib.3.2.10923
[26]
Weber MJ, Gioeli D (2004) Ras signaling in prostate cancer progression. J Cell Biochem 91: 13–25. doi: 10.1002/jcb.10683
